Melanoma of the EyeSymptoms, Doctors, Treatments, Advances & More
Learn About Melanoma of the Eye
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ophthalmology - Wills Eye Hospital
Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.
Jefferson Cancer - Honickman Center
Marlana Orloff is an Oncologist practicing medicine in Philadelphia, Pennsylvania. She has been practicing medicine for over 17 years. Dr. Orloff is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Liver Embolization. Dr. Orloff is board certified in Medical Oncology and Internal Medicine. Dr. Orloff is currently accepting new patients.
Summary: The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).
Summary: This phase I/Ib trial studies the side effects and best dose of intrathecal nivolumab, and how well it works in combination with intravenous nivolumab in treating patients with leptomeningeal disease. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.